BPC-157

Estimated Market Price

$19 – $70

Estimated for 5–10 mg vial · Based on verified supplier pricing

The gold standard recovery peptide. Supports gut lining integrity, tissue repair, and accelerated healing. Third-party tested, 99%+ purity guaranteed.

How it works

Activates growth factor receptors to speed up tissue repair, while protecting the gut lining and improving blood flow to injured areas.

Healing

Performance

Recovery & Longevity

bestseller

What to Expect

Days 1–3 Injection-site warmth; peptide begins upregulating growth factors. You might feel warmth or tingling near the injection site.

Week 1–2 Reduced inflammation and pain at injury sites noted. Less pain when moving; the injured area feels calmer.

Week 3–4 Visible tissue-repair acceleration; improved mobility. You can move more freely; stiffness fading noticeably.

Week 5–6 Structural remodeling of tendons and ligaments progresses. Old injuries feel structurally stronger and more stable.

Week 7–8 Peak regenerative benefits; assess need for continued use. Near full recovery; the area feels close to pre-injury.

Verified Suppliers

For research purposes only. These suppliers have been independently verified by PepSpace. We do not process sales directly.

PepSpace is not affiliated with any listed supplier

LarnaLabs Verified Supplier · larnalabs.com

NXPeptides Verified Supplier · nxpeptides.com

BioSynth Verified Custom Batch Supplier · biosynth.com

Peptide Sciences Unavailable · peptidesciences.com

Protocol & Dosage

Typical Dosage 250–500 mcg SC, 1–2 times daily

Administration Subcutaneous injection, Oral

Schedule 1–2 times daily; oral for gut issues

Protocol Duration 4–6 weeks

Half-Life ~4 hours (stable in gastric juice)

Side Effects & Safety

Tolerability Profile Mild

Generally well tolerated; side effects are mild and transient

Common Side Effects

Injection site redness or warmthmost users
Mild GI discomfort (oral route)some users

Less Common

Nauseaoccasional
Headacheoccasional
Mild dizzinessoccasional
Transient drop in blood pressureoccasional

Discontinue If

Severe allergic reaction (swelling, hives, difficulty breathing)
Persistent GI bleeding or black/tarry stools
Chest tightness or palpitations

Contraindications

Pregnancy or breastfeeding
Active GI malignancy
Known hypersensitivity to BPC-157

Data note: Limited human clinical data. Most safety evidence from animal studies; Phase II trials underway.

Always consult a qualified healthcare professional before use. This information is for research reference only and does not constitute medical advice.

Ask about BPC-157

How to Apply

Gather

Peptide vial, BAC water, alcohol swabs, insulin syringe

Sanitize

Wipe tops of both vials with alcohol swabs

Draw

Pull 1–2 mL of BAC water into syringe

Add Water

Release water slowly along vial wall, not directly on powder

Swirl

Roll between palms until dissolved. Never shake.

Store

Refrigerate 2–8°C, use within 30 days

Frequently Asked Questions

Yes. Bacteriostatic water (BAC water) is required to reconstitute lyophilized (freeze-dried) peptides. It contains 0.9% benzyl alcohol which prevents bacterial growth, keeping your reconstituted peptide safe for multiple uses over up to 30 days.

Unreconstituted: store at -20°C (freezer) for long-term, or 2–8°C (fridge) for short-term. After reconstitution: always refrigerate at 2–8°C and use within 30 days. Keep away from direct sunlight.

Results vary by individual and protocol. In research settings, measurable effects are typically observed within 1–4 weeks depending on the specific peptide, dosage, and application. Consult a qualified professional for guidance.

Verified suppliers typically include a full third-party COA verifying purity (99%+), identity, and sterility. We recommend only sourcing from vendors that provide batch-specific testing data.

We list verified suppliers above that have been independently reviewed for product quality, testing transparency, and shipping reliability. Always verify COA data before sourcing.

Compound Profile

Scientific data & classification for BPC-157

Also Known As Body Protection Compound-157, PL 14736, Bepecin

Classification Pentadecapeptide · Tissue Repair

Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

Molecular Formula C₆₂H₉₈N₁₆O₂₂

Molecular Weight 1,419.53 Da

CAS Number 137525-51-0

Half-Life ~4 hours (stable in gastric juice)

Origin Synthetic fragment of human gastric juice protein

Administration Subcutaneous injection, Oral

Status Research · Phase II clinical trials

Mechanism of Action Activates growth factor receptors to speed up tissue repair, while protecting the gut lining and improving blood flow to injured areas.

Research Overview BPC-157, a pentadecapeptide consisting of 15 amino acids, was first isolated and characterized in the early 1990s by a research group at the University of Zagreb led by Professor Predrag Sikirić. The peptide is derived from a protective protein found in human gastric juice, which partly explains its remarkable stability in highly acidic environments - a rare trait among bioactive peptides. Unlike most peptides that are rapidly degraded by gastric enzymes and hydrochloric acid, BPC-157 maintains its structural integrity throughout the gastrointestinal tract, enabling both parenteral and oral routes of administration in experimental models. Preclinical research spanning more than three decades has demonstrated a striking breadth of tissue-protective and regenerative effects. In tendon and ligament injury models, BPC-157 accelerates the outgrowth of tendon fibroblasts, increases type I collagen expression, and promotes the formation of the tendon-bone interface. Studies in rat models of Achilles tendon transection showed significantly faster recovery of biomechanical strength compared to controls. In the gastrointestinal system, BPC-157 has shown protective effects against a wide range of mucosal insults including ethanol, NSAIDs, and capsaicin-induced lesions, while also accelerating the healing of anastomosis sites and fistulas. Its vascular effects are equally notable - the peptide promotes angiogenesis through VEGF upregulation and has demonstrated the ability to counteract prolonged vasoconstriction. Neurological research has revealed interactions with the dopaminergic, serotonergic, GABAergic, and opioid systems, with studies showing protective effects in models of traumatic brain injury, spinal cord injury, and peripheral nerve damage. BPC-157 also appears to modulate the nitric oxide system in a bidirectional manner, potentiating NO release when it is deficient and attenuating it when overproduced. Despite this extensive preclinical evidence base - with over 100 published animal studies - human clinical trial data remains limited, with a few Phase II trials investigating its effects on inflammatory bowel disease and musculoskeletal conditions currently underway or recently completed.

Citations

Published findings on BPC-157 from peer-reviewed journals.

Pentadecapeptide BPC 157 promotes tendon healing via tendon outgrowth, cell survival, and cell migration

Chang CH, Tsai WC, et al. • 2011 PubMed

Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing

Gwyer D, Wragg NM, Wilson SL • 2019 PubMed

Stable Gastric Pentadecapeptide BPC 157 and Wound Healing

Seiwerth S, Milavic M, et al. • 2021 PubMed